The number of people with susceptibility test result for rifampicin in Malta
Malta: The number of people with susceptibility test result for rifampicin was 27 in 2021. ▲ Rising
Latest (2021)
27
Change on year
down 20.6%
World rank
129th
of 155 countries
All-time high
37
in 2019
All-time low
23
in 2017
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Malta, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
In 2021, the number of people with susceptibility test result for rifampicin in Malta stood at 27.
Compared with earlier readings it is down 20.6% on the previous year and up 17.4% over five years.
Malta ranks 129th of 155 countries on this measure, in the bottom quarter.
The number of people with susceptibility test result for rifampicin in Malta, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 23 | — |
| 2018 | 27 | +17.4% |
| 2019 | 37 | +37.0% |
| 2020 | 34 | -8.1% |
| 2021 | 27 | -20.6% |
Malta compared with similar countries
- Malta's 27 is below the median for high income countries, which is 142, 19% of the median. (61 countries reporting)
- Malta's 27 is below the median for Middle East, North Africa, Afghanistan & Pakistan, which is 406, 7% of the median. (16 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 29 | 23 | 37 | 3 |
| 2020s | 30.5 | 27 | 34 | 2 |
Countries ranked near Malta
- 126 Guam 35 compare
- 127 Marshall Islands 31 compare
- 128 Cyprus 29 compare
- 129 Micronesia, Federated States of 27 compare
- 131 United Arab Emirates 23 compare
- 132 Luxembourg 21 compare
More health data for Malta
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -1.1 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,737 deaths per 1,000 people (2090)
- Number of infants who die before age 1 4 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate 0.1693 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0194 units per person (2025)
- Population ages 00-04, male, annual growth rate 0.1495 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Malta?
- The number of people with susceptibility test result for rifampicin in Malta was 27 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Malta?
- The highest recorded value was 37 in 2019.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Malta?
- The lowest recorded value was 23 in 2017.
- How does Malta rank for the number of people with susceptibility test result for rifampicin?
- Malta ranks 129th out of 155 countries with data for 2021.
- Where does this Malta data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).